Trial · NCT02475824
Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP
NCT02475824, Phase 4, Completed, Dankook University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP. Trials, record NCT02475824. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02475824
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP
- NCT number
- NCT02475824
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 258 participants, actual
- Lead sponsor
- Dankook University
- Conditions
- Complication
- Interventions
- Midazolam®, "Meperidine" (pethidine®), Propofol®, Dexmedetomidine (Precedex®)
- First posted
- 2015-06-19
- Last updated
- 2018-04-06
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | the rates of cardiopulmonary complications | From start point of the procedure(ERCP) to 60 minutes after the procedure | respiratory depression (≤10 breaths/min); desaturation (SaO2\<90% with no recovery against a verbal stimulus or jaw extension); hypotension (systolic blood pressure \<90mmHg or 20% reduction from baseline mean blood pressure |
| Secondary | Sedation efficacy | From start point of the procedure(ERCP) to 1 hour after the procedure | Modified Observe's Assessment of Alertness and Sedation: 5-responds readily to name spoken in normal tone, 4-lethargic response to name spoken in normal tone, 3-responds only after name is called loudly and/or repeatedly, 2-responds only after mild prodding or shaking, 1-does not respond to mild prodding or shaking, 0-does not respond to noxious stimulus. |
| Secondary | procedural satisfaction | From start point of the procedure(ERCP) to 1 day after the procedure | respective visual analog scale (VAS; 0=no pain/ no satisfaction, 10=worst pain imaginable/full satisfaction |
| Secondary | Speed of recovery | From start point of the procedure(ERCP) to 1 hour after the procedure | speed of recovery (modified Aldrete score) are recorded at 5-minute intervals until discharge from the recovery room |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02475824
GET https://conductscience.org/api/trials/v1/NCT02475824/registered